304874-05-3 Usage
Uses
Used in Medicinal Chemistry:
Ethyl 5-amino-1-(2-fluorophenyl)-1H-pyrazole-3-carboxylate is used as a chemical intermediate for the synthesis of various pharmaceutical compounds. Its unique structure and potential biological activities make it a promising candidate for the development of new drugs.
Used in Drug Development:
Ethyl 5-amino-1-(2-fluorophenyl)-1H-pyrazole-3-carboxylate is used as a lead compound in drug discovery and development. Its potential pharmacological properties and therapeutic applications need to be further explored through research and studies.
Used in Pharmaceutical Industry:
Ethyl 5-amino-1-(2-fluorophenyl)-1H-pyrazole-3-carboxylate is used as a key component in the formulation of new drugs. Its unique chemical structure and potential biological activities contribute to the development of innovative therapeutic agents.
Check Digit Verification of cas no
The CAS Registry Mumber 304874-05-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,0,4,8,7 and 4 respectively; the second part has 2 digits, 0 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 304874-05:
(8*3)+(7*0)+(6*4)+(5*8)+(4*7)+(3*4)+(2*0)+(1*5)=133
133 % 10 = 3
So 304874-05-3 is a valid CAS Registry Number.
304874-05-3Relevant academic research and scientific papers
AMINO-SUBSTITUTED 3-HETEROAROYLAMINO-PROPIONIC ACID DERIVATIVES AND THEIR USE AS PHARMACEUTICALS
-
Page/Page column 81, (2012/08/08)
Amino-substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals The present invention relates to compounds of the formula (I), wherein A, D, E, G, R10 R11, R30 R40 R50
AMINO-SUBSTITUTED 3-HETEROAROYLAMINO-PROPIONIC ACID DERIVATIVES AND THEIR USE AS PHARMACEUTICALS
-
Page/Page column 27, (2012/09/22)
The present invention relates to compounds of the formula I, wherein A, D, E, G, R10, R11, R30, R40, R50 and R60 have the meanings indicated in the claims, which are valuable pharmaceutical active compounds. They are inhibitors of the protease cathepsin A, and are useful for the treatment of diseases such as atherosclerosis, heart failure, renal diseases, liver diseases or inflammatory diseases, for example. The invention furthermore relates to processes for the preparation of the compounds of the formula I, their use and pharmaceutical compositions comprising them.
